top of page
Search


Apotek Selected for NSF I-Corps Spark Cohort on AI/ML and Cancer Care
Translating AI-powered research into real-world cancer impact Apotek Joins NSF I-Corps Spark Special Cohort on AI/ML and Cancer Care Taipei | [November 12, 2025] — Vizuro is proud to announce that our Apotek platform has been selected for the National Science Foundation (NSF) I-Corps Spark Cohort , beginning November 13, 2025 . This specialized program focuses on AI/ML-powered innovations in cancer research and care , empowering teams to translate cutting-edge science into
Esther Chen
Nov 112 min read


Vizuro and NCKU Forge Partnership to Accelerate AI-Driven Biologics Innovation
Partnership with Professor Woei-Jer Chuang of NCKU to explore AI-powered discovery in protein drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with NCKU Taipei | [October 27, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI and generative AI for drug discovery, today announced the signing of a Memorandum of Understanding (MOU) with Professor Woei-Jer Chuang, Ph.D., of the Department of Biochemistry and Molecular Biology, Na
Esther Chen
Oct 262 min read


Vizuro Signs Memorandum of Understanding with Chang Gung University of Science and Technology to Advance AI-Driven Drug Discovery
Partnership with Professor Tsong-Long Hwang of CGUST to explore AI-powered innovations in small molecule drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with CGUST Taipei | [August 22, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI and generative AI technology, announced today that it has signed a Memorandum of Understanding (MOU) with Tsong-Long Hwang, Ph.D., Vice President and Distinguished Professor at Chang Gung U
Esther Chen
Aug 222 min read


Evaluating Drug Safety from Real-World Evidence: Congratulating Vizuro Team’s Contribution to Hematology Research
We're excited to share that a recent academic paper co-authored by our Data Scientist. Ling-Yu Cai, along with a team of MD/PhD...
Yu-Feng Wei
Jul 81 min read


Vizuro Champions a New Era in AI Marketing Through Strategic Alliance with iKala
Expanding Global Reach with Kolr's Rebranding and Cutting-Edge AI Technologies (Left to right) Vizuro Co-founder and CEO, Yu-Feng Wei;...
Yu-Feng Wei
Jan 152 min read


Vizuro Selected for Wet Lab Validation in Winter'24 Adaptyv Bio's EGFR Binder Design
Fig 1. Adaptyv Bio “Protein Design Competition Round2” Competition Overview Protein binding remains one of the most challenging aspects...
Yu-Feng Wei
Jan 103 min read


Vizuro and DCB Join Forces to Revolutionize Drug Discovery and Precision Medicine with Causal Generative AI
Vizuro and DCB announced the signing of a Memorandum of Understanding (MOU) Vizuro LLC, a leading innovator in multimodal causal AI...
Yu-Feng Wei
Dec 25, 20243 min read


Vizuro Joins NVIDIA Inception
We are thrilled to announce that Vizuro has joined NVIDIA Inception , a program that nurtures startups revolutionizing industries with...
Yu-Feng Wei
Nov 26, 20241 min read
bottom of page